INmune Bio, Inc. (INMB)
USD 4.57
(-8.33%)
USD 4.57
(-8.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 155 Thousand | 374 Thousand | 181 Thousand | 10.91 Thousand | 77.68 Million | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 155 Thousand | 374 Thousand | 181 Thousand | 10.91 Thousand | 77.68 Million | - |
| Operating Expenses | 29.89 Million | 26.32 Million | 29.33 Million | 12.23 Million | 9.29 Million | 12.44 Million |
| Selling, General and Administrative Expenses | 9.62 Million | 9.25 Million | 8.79 Million | 6.32 Million | 6.01 Million | 11.33 Million |
| Research and Development Expenses | 20.27 Million | 17.06 Million | 20.54 Million | 5.91 Million | 3.28 Million | 1.1 Million |
| Other Expenses | - | -1.34 Million | -1.18 Million | 128.51 Thousand | - | - |
| Cost and Expenses | 29.89 Million | 26.32 Million | 29.33 Million | 12.23 Million | 9.29 Million | 12.44 Million |
| Operating Income | -29.74 Million | -25.95 Million | -29.15 Million | -12.22 Million | -7.75 Million | -12.44 Million |
| Interest Expense | - | 1.34 Million | - | - | - | - |
| Income Tax Expense | - | 1.34 Million | -29.15 Million | -12.22 Million | 1.46 Million | -161.14 Thousand |
| Earnings before Tax | -30 Million | -27.29 Million | -30.34 Million | -12.09 Million | -7.67 Million | -12.44 Million |
| Net Income | -30 Million | -28.64 Million | -30.34 Million | -12.09 Million | -9.14 Million | -12.44 Million |
| Earnings Per Share Basic | -1.67 | -1.60 | -1.88 | -1.01 | -0.89 | -1.11 |
| Earnings Per Share Diluted | -1.67 | -1.60 | -1.88 | -1.01 | -0.89 | -1.11 |
| Weighted Average Shares Outstanding | 17.98 Million | 17.92 Million | 16.13 Million | 11.98 Million | 10.27 Million | 11.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.98 Million | 17.92 Million | 16.13 Million | 11.98 Million | 10.27 Million | 11.21 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | - | -69.39 | -161.07 | -1120.16 | -0.14 | - |
| Profit Margin | -193.60 | -76.60 | -167.62 | -1108.39 | -0.12 | - |
| EBITDA | - | - | - | - | - | - |
| Earnings Before Tax Margin | -191.88 | -69.39 | -161.07 | -1120.16 | -0.10 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 14 Thousand | 28 Thousand | 155 Thousand | 43 Thousand |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | 14 Thousand | 28 Thousand | 155 Thousand | 43 Thousand |
| Operating Expenses | 12.28 Million | 9.86 Million | 11.03 Million | 8.4 Million | 29.89 Million | 8.57 Million |
| Selling, General and Administrative Expenses | 2.21 Million | 2.81 Million | 2.33 Million | 2.4 Million | - | 2.58 Million |
| Research and Development Expenses | 10.06 Million | 7.05 Million | 8.69 Million | 6 Million | - | 5.98 Million |
| Other Expenses | - | 119 Thousand | -8000.00 | -29 Thousand | -267 Thousand | -35 Thousand |
| Cost and Expenses | 12.28 Million | 9.86 Million | 11.03 Million | 8.4 Million | 29.89 Million | 8.57 Million |
| Operating Income | -12.28 Million | -9.86 Million | -11.01 Million | -8.37 Million | -29.74 Million | -8.52 Million |
| Interest Expense | - | - | - | -113 Thousand | - | - |
| Income Tax Expense | - | -9.86 Million | -11.01 Million | 14.82 Million | -29.74 Million | -8.52 Million |
| Earnings before Tax | -12.09 Million | -9.74 Million | -11.02 Million | -8.4 Million | -30 Million | -8.56 Million |
| Net Income | -12.09 Million | -9.74 Million | -11.02 Million | -8.4 Million | -30 Million | -8.56 Million |
| Earnings Per Share Basic | -0.60 | -0.50 | -0.61 | -0.47 | - | -0.48 |
| Earnings Per Share Diluted | -0.60 | -0.50 | -0.61 | -0.47 | - | -0.48 |
| Weighted Average Shares Outstanding | 20.18 Million | 19.3 Million | 18.02 Million | 17.95 Million | 17.98 Million | 18 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.18 Million | 19.3 Million | 18.02 Million | 17.95 Million | 17.98 Million | 18 Million |
| Gross Margin | - | - | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | - | -786.93 | -299.25 | - | -198.33 |
| Profit Margin | - | - | -787.50 | -300.29 | -193.60 | -199.14 |
| EBITDA | -12.28 Million | -9.86 Million | -11.01 Million | -8.37 Million | - | -8.52 Million |
| Earnings Before Tax Margin | - | - | -786.93 | -299.25 | -191.88 | -198.33 |
2686
HAWPF
603365
GGNDF
ELIMP
LFVN